Virus infectivity and antibody neutralization titers for respiratory syncytial virus were determined in cell cultures in microtiter plates. After an appropriate incubation period, the cells were fixed, and an enzymelinked immunosorbent assay was performed directly in the microtiter plates for detection of virus. Results could be read and recorded automatically, which is especially helpful when running large numbers of tests. of bovine anti-RSV serum (BaRSV) (Burroughs Wellcome Co., Research Triangle Park, N.C.) diluted in PBS-0.5% gelatin plus 0.5% Tween 20 and 2% normal goat serum was added and incubated for 1 h at 35.5°C. The contents were aspirated, the wells were washed, and 75 pl of peroxidaseconjugated, goat anti-bovine immunoglobulin G (IgG) (Kirkegaard and Perry Laboratories, Inc., Gaithersburg, Md.) diluted in PBS-0.5% gelatin-0.5% Tween 20-2% normal goat serum was added and incubated for 1 h at 35.0°C. The contents of the wells were aspirated again, the wells were washed, and 125 ,l1 of substrate (0.4 mg of ophenylenediamine dihydrochloride per ml, 0.015% H202) in 0.15 M citrate phosphate buffer (pH 5.5) was added and incubated at room temperature for 40 to 45 min. The reaction was stopped with 3.5 M HCl, and the A490 was read with an MR580 Microelisa Auto Reader (Dynatech Laboratories, Inc., Alexandria, Va.). Each dilution of antibody was run in duplicate, and each plate included control wells with uninfected cells, a back titration, i.e., titration of the virus inoculum in MEM-2% FBS, and a titration of a preimmune, or nonneutralizing, antibody. An absorbance reading of .3 standard deviations above the mean of 15 control wells was considered to be evident bf virus replication. The dilutions of BaRSV (1:1,000) and goat anti-bovine IgG (1:5,000) used throughout the study initially were determined by checkerboard titrations.
The antigenic characterization of respiratory syncytial virus (RSV) strains requires testing with a variety of polyclonal sera and monoclonal antibodies produced against representative strains of RSV. Virus neutralization tests are an integral part of these studies, and large numbers of assays often must be performed simultaneously. We developed a microneutralization test in which virus replication is detected by enzyme-linked immunosorbent assay (ELISA) . With this technique, we are able to run large numbers of neutralization tests and to automate the reading and recording of results.
The Long strain of RSV (2) Four polyclonal anti-RSV sera and two preimmune sera were tested on three separate days. The six sera were a horse anti-RSV serum (F-HaRSV) and normal horse serum from Flow Laboratories; a horse anti-RSV serum from the Centers for Disease Control, Atlanta, Ga. (C-HaRSV); the BaRSV (described above) and a normal bovine serum from Burroughs Wellcome; and a human convalescent-phase serum [LA(12/84)]. Four previously described MAbs against RSV (1) were also tested. One, 100-7G, is against N, and the other three, 92-llC, 131-2A, and 133-1H, are against the fusion protein.
The four polyclonal sera had a range of neutralizing titers. C-HaRSV and BaRSV had low neutralizing titers, LA(12/84) had a moderate titer, and F-HaRSV had a high titer (Table 1 and Fig. 1 ). For the same serum and virus inoculum, the median difference in neutralizing antibody titer between test runs was 8-fold, with a range of 1-to 128-fold. Much of this difference could be attributed to day-to-day variation in the back titer of virus. The neutralizing antibody titers for a given serum were inversely correlated with the back titer of virus. The coefficients of correlation were -0.79 for FHaRSV, -0.79 for C-HaRSV, -0.46 for BaRSV, and -0.82 for LA(12/84). Within a test run, the median difference in the back titer for the same virus inoculum was 1.5-fold, and the range was 1.4-to 3.0-fold. Between test runs, the median difference in the back titer for the same virus inoculum was 4.7-fold, and the range was 1.0-to 16-fold.
The titers by tissue culture ELISA were compared with those obtained by reading CPE. Two investigators independently read the microtiter plates for CPE just before the plates were fixed for the ELISA test, and the CPE titer by each investigator was compared with the corresponding ELISA titer. Among 20 comparisons of back-titer determinations by ELISA and CPE analysis, the titers were within 2-fold of each other for 11 (55%), the titer by CPE was .4-fold higher for 5 (25%), and the titer by ELISA was .4-fold higher for 4 (20%). Among 63 comparisons of antibody titer determinations by ELISA and CPE analysis, the CPE for one test of one serum sample was considered to be unreadable by one of the investigators, the titers were within 2-fold of each other for 30 (48%), the titer by CPE was .4-fold higher for 19 (30%), and the titer by ELISA was .4-fold higher for 14 (22%). The distribution of higher and lower titers by ELISA was not significantly different from that by CPE.
One of the four MAbs, 133-1H, neutralized RSV, and one, 100-7G, did not, as expected (Fig. 1) (7, 9, 10) were used to detect virus replication and to determine viral infectivity and antibody neutralization titers. However, these tests were not performed in microtiter plates. Several investigators have described tests similar to this test, in which virus replication in microtiter plates was detected by immunofluorescence assays (8) , immunoperoxidase staining (3, 4), or ELISA (4). In the test with ELISA, the substrate solution was transferred to a second microtiter plate before absorbance was read (4). The major advantage of the ELISA test described here over these other tests and tests in which CPE was used to detect viral replication is that results can be read and recorded automatically from the plate in which the test is performed. This simplifies the test procedure and eliminates one source of recording errors. In the case of CPE analysis, it also eliminates the fatigue and subjectivity associated with reading large numbers of tests.
Another advantage of ELISA over reading CPE is its specificity. The ELISA results are not subject to nonspecific changes in cells which can make accurate readings of CPE difficult. The specificity of the ELISA test is independent of changes in the cells and, instead, is dependent on the quality of the reagents and the correct performance of the test. When good quality reagents are available, the test is technically easy to perform and monitor and should give results specific for viral replication.
This tissue culture ELISA has the potential for application to a wide variety of serologic test systems in virology. For example, we adapted this system to test for RSV-specific IgG antibodies in human sera and to study competitive binding between MAbs. It should also be applicable to test systems in which the virus replicates but gives indistinct or no CPE.
